Djoko Heri Hermanto
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

PERBEDAAN KUALITAS FRESH FROZEN PLASMA YANG DICAIRKAN DENGAN METODE KONVENSIONAL DAN DENGAN METODE ALAT FFP THAWER Retno, Didin; Riza Zainal, Ahmad; D Machsoos, Budi; Heri Hermanto, Djoko; Oktya Wardhani, Shinta
journal of internal medicine Vol. 13, No. 1 Januari 2012
Publisher : journal of internal medicine

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (368.882 KB)

Abstract

Saiful Anwar Hospital (SAH) doesn?t have standardized Fresh Frozen Plasma (FFP) liquefying tools. Standard OperatingProcedure (SOP) to liquify FFP at SAH is put the FFP on the table until diluted. Recently a new Thawer of FFP wasdeveloped in SAH. In this study we compared between the two methods which are convensional and the new one. Thirttytwo bag of FFP were divided in two different treatments which is group of new Thawer and the convensional. Eachliqueed bag of FFP was recorded the time of liquefaction, aPTT, PPT and INR. Statistical analyses using independent Ttest or Mann-Whitney as alternative. In this study found mean time of liquefaction of FFP on Thawer group were shorterthan conventional method 25.32 ± 3.4 vs 50.38 ± 5.52 minutes and statistically signicant (p < 0.05). Mean of aPTT onnew Thawer group is 36.79 ± 5.94; but on conventional method is 36.94 ± 5.53 second (p = 0.67). Mean of PPT 11.71 ±0.95 second on new Thawer group and 11.84 ± 2.22 second on conventional method (p = 0.249). Mean INR each groupwere 1.02 ± 0.08 on new Thawer group and 1.03 ± 0.19 on conventional method (p = 0.234). This study shows that newFFP Thawer liquifay FFP more quickly than conventional method without decreasing the quality of FFP.
Clinical Response of Convalescent Plasma Therapy in COVID-19 Patients in Dr. Saiful Anwar General Hospital Niniek Budiarti Burhan; Herwindo Pudjo Brahmantyo; Djoko Heri Hermanto; Putu Moda Arsana
Jurnal Kedokteran Brawijaya Vol. 31 No. 4 (2021)
Publisher : Fakultas Kedokteran Universitas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.jkb.2021.031.04.5

Abstract

The use of convalescent plasma has been beneficial for more than a century to treat various infections.  The lack of effective treatment currently available for COVID-19 has reemerged the use of convalescent plasma as a potential therapeutic option. This is an observational descriptive study in 13 COVID-19 patient who got convalescent Plasma. Consist of 11 (84%) male patient, 2 (16%) female patient. Divided into two groups based on severity, and outcome. 38% patient included in severe disesase and 62% patient in critically Ill condition. 30% patient who got convalescent plasma deceased, and 70% had a resolve condition.